Researchers at the Michigan Medical School have published a paper on Parametric Response Mapping (PRM) in patients with COPD.
Researchers at the Michigan Medical School have published a paper on Parametric Response Mapping (PRM) in patients with COPD. As part of a national COPDGene study, the researchers used PRM to analyze CT scans of the lungs. The technique allowed them to distinguish between early damage to small airways and emphysema. The results correlated to standard lung tests. “In the last decade, CT scan techniques for imaging COPD have improved steadily, but PRM is the missing link—giving us a robust way to see small airway disease and personalize treatment,” says Dr. Ella Kazerooni, radiology professor and leader of the University of Michigan Lung Imaging Program. PRM was originally developed to track thetreatment response in brain tumors. Imbio, has already licensed the University of Michigan patents to develop PRM as an early detection tool for treatment response in brain tumors and has now begun developing the technology for COPD diagnosis and treatment.
COPD is the third highest cause of death in the U.S., affecting nearly 24 million.